Novel insights from meta-analysis: the efficacy of ginsenosides in non-alcoholic fatty liver disease

Novel insights from meta-analysis: the efficacy of ginsenosides in non-alcoholic fatty liver disease

BackgroundThe global prevalence of non-alcoholic fatty liver disease (NAFLD) has surged, largely driven by modern lifestyle changes and dietary shifts. As these factors profoundly impact human health, exploring effective therapeutic strategies for NAFLD has become a pressing medical concern. Previou...

Full description

Saved in:

Bibliographic Details
Main Authors:	Liyuan Hao, Qing Peng, Shenghao Li, Xiaoyu Hu, Huimin Yan
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-05-01
Series:	Frontiers in Pharmacology
Subjects:	ginsenoside animal model NAFLD preclinical studies meta-analysis
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2025.1564852/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

In vivo metabolism, pharmacokinetics, and pharmacological activities of ginsenosides from ginseng
by: Yuhao Wang, et al.
Published: (2025-09-01)

The inhibitory effects of ginsenosides on periodontitis pathogenic bacteria
by: Qiuyang Lei, et al.
Published: (2025-03-01)

Inhibitory Effect of Exosomes Loaded with Ginsenoside Rh2 on Growth of Hepatocellular Carcinoma Cells
by: Meile LI, et al.
Published: (2025-07-01)

Unraveling Ginsenoside Rg1’s osteoprotective pathways in zebrafish models of glucocorticoid induced osteoporosis via transcriptomics
by: Xinyu Fan, et al.
Published: (2025-08-01)

Research Progress on the Structural Modification and Activity of Ginsenosides
by: Ruixiu XIE, et al.
Published: (2025-08-01)

Emodin, a rising star in the treatment of glycolipid metabolism disorders: a preclinical systematic review and meta-analysis
by: Yang Xiao, et al.
Published: (2025-05-01)

Ayurvedic management of non-alcoholic fatty liver disease with obesity and rheumatoid arthritis– A case report
by: Amit Nakanekar, et al.
Published: (2025-08-01)

Anticancer Mechanisms of Ginsenoside Compound K: A Review
by: Yu-Po Lee, et al.
Published: (2025-05-01)

Ginsenoside CK and retinol on UVA-induced photoaging exert the synergistic effect through antioxidant and antiapoptotic mechanisms
by: Jingyin Zhang, et al.
Published: (2025-05-01)

Association between lipid accumulation product and non-alcoholic fatty liver disease with normal weight: a population-based study
by: Lingde Shen, et al.
Published: (2025-08-01)

Therapeutic effects and mechanisms of Tripterygium wilfordii extracts in rheumatoid arthritis: a systematic review and meta-analysis of preclinical studies
by: Kai Chen, et al.
Published: (2025-07-01)

Ginsenoside Rg1 treatment alleviates renal fibrosis by inhibiting the NOX4–MAPK pathway in T2DM mice
by: Pengmin Ji, et al.
Published: (2023-12-01)

Nanoparticle conjugation of ginsenoside Rh2 enhanced antitumor efficacy on hepatocellular carcinoma
by: Fengkai Sun, et al.
Published: (2025-08-01)

Association Between High Sensitivity Cardiac Troponin and All-Cause and Cardiovascular Mortality in Adults at Risk of Non-Alcoholic Fatty Liver Disease: A Cohort Study
by: Enfa Zhao, et al.
Published: (2025-04-01)

Research of <i>PNPLA3</i> I148M Gene Polymorphism in Patients with Non-Alcoholic Fatty Liver Disease, with Liver Cirrhosis and with Hepatocellular Carcinoma
by: V. V. Petkau, et al.
Published: (2023-11-01)

Practical Aspects of Clinical Manifestations, Pathogenesis and Therapy of Alcoholic Liver Disease and Non-alcoholic Fatty Liver Disease: Expert Opinion
by: V. V. Tsukanov, et al.
Published: (2023-11-01)

Ginsenoside Rb1 inhibits proliferation and promotes apoptosis by regulating HMGB1 in uterine fibroid cells
by: Jianqiang Zhang, et al.
Published: (2019-12-01)

Ginsenoside Rh2 inhibits breast cancer cell growth via<?A3B2 ACK?>ERβ-TNFα pathway
by: Peng Kunjian, et al.
Published: (2022-05-01)

Ginsenoside Rb1 alleviates renal tubular epithelial cell injury in diabetic kidney disease by inhibiting the aldose reductase activity
by: Wang Meng-jing, et al.
Published: (2025-07-01)

Total ginsenosides enhance γ-globin expression and fetal hemoglobin production in β-thalassemia models
by: Dongling Cai, et al.
Published: (2025-08-01)

Ginsenoside Rg1 controls CKLF1-mediated apoptosis to reduce hypoxic/reoxygenation injury in HT22 cells
by: Jinping Liang, et al.
Published: (2025-04-01)

Ginsenoside Rh2 repressed the progression of prostate cancer through the mitochondrial damage induced by mitophagy and ferroptosis
by: Zhen He, et al.
Published: (2025-08-01)

Ginsenoside Re ameliorates thioacetamide-induced acute liver injury through inhibiting autophagy-NLRP3 inflammasome pathway
by: Jing Lin, et al.
Published: (2025-06-01)

Lactate transporter MCT4 regulates the hub genes for lipid metabolism and inflammation to attenuate intracellular lipid accumulation in non-alcoholic fatty liver disease
by: Yannian Gou, et al.
Published: (2025-07-01)

Prevalence of non-alcoholic fatty liver disease in out-patients of the Russian Federation: DIREG 2 study results
by: V. T. Ivashkin, et al.
Published: (2015-12-01)

Harnessing Jasmonate Pathways: PgJAR1’s Impact on Ginsenoside Accumulation in Ginseng
by: Ru Zhang, et al.
Published: (2025-03-01)

Ginsenoside Rh4 inhibits colorectal cancer via the modulation of gut microbiota-mediated bile acid metabolism
by: Xue Bai, et al.
Published: (2025-06-01)

Therapeutic Targeting of PPAR&gamma; in Nonalcoholic Fatty Liver Disease: Efficacy, Safety, and Drug Development
by: Zhou Z, et al.
Published: (2025-08-01)

A Literature Review of Glutathione Therapy in Ameliorating Hepatic Dysfunction in Non-Alcoholic Fatty Liver Disease
by: Michelle Thuy Nguyen, et al.
Published: (2025-03-01)

Association between exposure to air pollutants and NAFLD/MAFLD: a meta-analysis
by: Zixiao Zhu, et al.
Published: (2025-08-01)

Challenges and needs in the management of non-alcoholic fatty liver disease from the perspective of gastroenterology and hepatology specialists: a qualitative study
by: Farzad Salmanizadeh, et al.
Published: (2025-05-01)

Association between GNRI and risk of non-alcoholic fatty liver disease in non-obese individuals: a Chinese longitudinal prospective cohort study
by: Linlin Shen, et al.
Published: (2025-05-01)

Chronic lipopolysaccharide exposure promotes cognitive impairments by activating TRPC6-AIM2 inflammasome signaling and the regulation of ginsenoside Rg1 in Trpc6 −/− mice
by: Yinglin Fu, et al.
Published: (2025-07-01)

The acute effect of metabolic cofactor supplementation: a potential therapeutic strategy against non‐alcoholic fatty liver disease
by: Cheng Zhang, et al.
Published: (2020-04-01)

THE PREVALENCE OF NON-ALCOHOLIC FATTY LIVER DISEASE IN OUTPATIENTS IN THE FAR EAST FEDERAL DISTRICT
by: V. A. Nevzorova, et al.
Published: (2017-05-01)

Polygala tenuifolia Willd. Extract delays non-alcoholic fatty liver disease progression in rats via the COX2 and PERK-elF2α-ATF4 pathway
by: Zhiliang Sun, et al.
Published: (2025-06-01)

Investigation of predictive factors for fatty liver in children and adolescents using artificial intelligence
by: Aliakbar Sayyari, et al.
Published: (2025-08-01)

Prevalence of metabolic dysfunction-associated fatty liver disease among information technology employees in India
by: Bharam Bhargava, et al.
Published: (2025-03-01)

Development and validation of a nomogram-based risk prediction model for non-alcoholic fatty liver disease (NAFLD): a logistic regression analysis in a physical examination population
by: Jing Lan, et al.
Published: (2025-07-01)

Food-derived extracellular vesicles for treatment of osteoporosis: a systematic review and meta-analysis of preclinical animal studies
by: Hongchen Shi, et al.
Published: (2025-08-01)